Blood test could guide pancreatic cancer therapy
NCT ID NCT04241367
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at whether a simple blood test (liquid biopsy) can find genetic markers that predict how well pancreatic cancer treatments work. Researchers analyzed DNA from tumors circulating in the blood of 420 patients with pancreatic cancer. The goal was to discover biomarkers that could help personalize treatment in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose better treatments for pancreatic cancer patients based on their tumor's genetic markers.
- What could go wrong
- This is an observational study that does not test a new treatment, so it will not directly improve patient outcomes. The findings may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
420 people
The number who actually took part.
- Started
-
Mar 2019
- Finished
-
Dec 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Inpatient or outpatient
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with pathologically confirmed pancreatic adenocarcinoma. Exclusion Criteria: * Patients disagree with the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pancreas adenocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Goyang-si, Gyeonggi-do, 410-769, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can chemo before surgery extend lives in pancreatic cancer?
- Could a simple blood test catch pancreatic cancer before It's too late?
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
- New drug THE-0504 enters human testing for tough cancers
- Gut bacteria may forecast surgery risks in pancreatic cancer patients
- New antibody combo takes on Hard-to-Treat cancers